Training physician-scientists in rheumatology and clinical immunology.
Academic Rheumatology and Clinical Immunology
This program at UCSF is designed to help doctors who want to specialize in treating autoimmune diseases learn new research skills and techniques, so they can improve care and treatments for patients like you.
Quick facts
| Grant type | Training grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11101320 on NIH RePORTER |
What this research studies
This program at UCSF aims to train physician-scientists in the field of rheumatology and clinical immunology. Participants will engage in hands-on research experiences under the guidance of experienced faculty, learning advanced techniques and methodologies relevant to rheumatic diseases. The training covers both basic and clinical sciences, focusing on translating research findings into better healthcare practices and treatments for patients with these conditions. The program also emphasizes ethical research conduct and effective communication of scientific findings.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research are individuals with rheumatologic diseases or those interested in the advancements in their treatment.
Not a fit: Patients with non-rheumatologic conditions or those not seeking advanced treatment options in rheumatology may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved recognition and treatment options for patients suffering from rheumatic diseases.
How similar studies have performed: Previous research training programs in rheumatology have shown success in advancing treatment options and improving patient outcomes.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Zikherman, Julie — University of California, San Francisco
- Study coordinator: Zikherman, Julie
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.